ImVitro is a B2B SaaS provider that applies computer vision and AI to the IVF fertility imaging process via its EMBRYOLY platform. The platform analyzes over 30 clinical data points to produce a hybrid score incorporating patient BMI, uterus receptivity, spermatozoa mobility and other metrics to help standardize and personalize results. Clinics can also offer patients a portal to receive simplified lab results. More than a dozen clinics across Europe use the platform routinely. The company has offices in Paris and London and is considering opening an office in Spain in 2023. ImVitro raised $2.5m in seed funding to support growth and product development.

Total raised

$3M

Funding rounds

1

Latest round

Seed

Latest activity

Dec 2022